[DPHARMA] YoY Annualized Quarter Result on 30-Sep-2023 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
08-Nov-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Sep-2023 [#3]
Profit Trend
QoQ- -16.33%
YoY- -16.63%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 826,698 716,301 726,342 658,308 581,088 584,942 510,784 8.34%
PBT 83,441 74,977 92,672 87,808 74,248 75,826 56,010 6.86%
Tax -20,025 -16,120 -22,070 -21,185 -17,692 -18,173 -11,648 9.44%
NP 63,416 58,857 70,601 66,622 56,556 57,653 44,362 6.13%
-
NP to SH 63,416 58,857 70,601 66,622 56,556 57,653 44,362 6.13%
-
Tax Rate 24.00% 21.50% 23.82% 24.13% 23.83% 23.97% 20.80% -
Total Cost 763,282 657,444 655,741 591,685 524,532 527,289 466,421 8.54%
-
Net Worth 692,598 673,359 647,522 612,147 584,565 505,919 501,487 5.52%
Dividend
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Div 12,825 6,412 6,348 6,278 4,639 8,994 13,197 -0.47%
Div Payout % 20.23% 10.90% 8.99% 9.42% 8.20% 15.60% 29.75% -
Equity
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Net Worth 692,598 673,359 647,522 612,147 584,565 505,919 501,487 5.52%
NOSH 961,942 961,942 952,239 941,765 706,026 680,106 661,881 6.42%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 7.67% 8.22% 9.72% 10.12% 9.73% 9.86% 8.69% -
ROE 9.16% 8.74% 10.90% 10.88% 9.67% 11.40% 8.85% -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 85.94 74.46 76.28 69.90 83.50 86.71 77.41 1.75%
EPS 6.59 6.15 7.45 7.08 8.21 8.65 6.79 -0.49%
DPS 1.33 0.67 0.67 0.67 0.67 1.33 2.00 -6.56%
NAPS 0.72 0.70 0.68 0.65 0.84 0.75 0.76 -0.89%
Adjusted Per Share Value based on latest NOSH - 961,942
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 85.94 74.46 75.51 68.44 60.41 60.81 53.10 8.34%
EPS 6.59 6.15 7.34 6.93 5.88 5.99 4.61 6.13%
DPS 1.33 0.67 0.66 0.65 0.48 0.93 1.37 -0.49%
NAPS 0.72 0.70 0.6731 0.6364 0.6077 0.5259 0.5213 5.52%
Price Multiplier on Financial Quarter End Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 30/09/24 29/09/23 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 -
Price 1.36 1.20 1.30 1.81 3.16 1.40 1.23 -
P/RPS 1.58 1.61 1.70 2.59 3.78 1.61 1.59 -0.10%
P/EPS 20.63 19.61 17.53 25.59 38.88 16.38 18.30 2.01%
EY 4.85 5.10 5.70 3.91 2.57 6.10 5.47 -1.98%
DY 0.98 0.56 0.51 0.37 0.21 0.95 1.63 -8.12%
P/NAPS 1.89 1.71 1.91 2.78 3.76 1.87 1.62 2.60%
Price Multiplier on Announcement Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 08/11/24 08/11/23 09/11/22 18/11/21 12/11/20 29/11/19 28/11/18 -
Price 1.25 1.22 1.39 1.62 4.04 1.39 1.07 -
P/RPS 1.45 1.64 1.82 2.32 4.84 1.60 1.38 0.82%
P/EPS 18.96 19.94 18.75 22.90 49.71 16.26 15.92 2.95%
EY 5.27 5.02 5.33 4.37 2.01 6.15 6.28 -2.87%
DY 1.07 0.55 0.48 0.41 0.17 0.96 1.87 -8.87%
P/NAPS 1.74 1.74 2.04 2.49 4.81 1.85 1.41 3.56%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment